Keefe, Bruyette & Woods raises Civista Bancshares stock price target to $27

Published 24/10/2025, 13:58
Keefe, Bruyette & Woods raises Civista Bancshares stock price target to $27

Investing.com - Keefe, Bruyette & Woods raised its price target on Civista Bancshares (NASDAQ:CIVB) to $27.00 from $26.00 on Friday, while maintaining an Outperform rating on the stock.

The firm cited Civista’s "outstanding" third-quarter results, with all major line items exceeding expectations and the net interest margin (NIM) expanding 11 basis points on an adjusted basis.

According to Keefe, Bruyette & Woods, Civista management provided an optimistic outlook, projecting the margin to increase an additional 5 basis points in the fourth quarter while loan growth is expected to accelerate to mid- to high single-digit range in 2026.

The research firm noted growing contributions from Civista’s Commercial and Industrial (C&I) vertical would support this loan growth acceleration.

Keefe, Bruyette & Woods also highlighted that Civista’s acquisition of Farmers remains on track to close in November, a deal expected to provide 10% EPS accretion while enhancing the bank’s branch network in its home Cleveland metropolitan statistical area.

In other recent news, Civista Bancshares, Inc. reported a robust financial performance for the third quarter of 2025. The company achieved earnings per share of $0.68, surpassing analysts’ forecasts of $0.60 by 13.33%. Additionally, Civista Bancshares’ revenue exceeded expectations, reaching $44.1 million compared to the projected $43.63 million. These results highlight the company’s ability to outperform market predictions in both earnings and revenue. Despite the positive financial outcomes, broader market trends led to a slight decline in the stock price, though this was not related to the company’s specific performance. Investors may find the company’s ability to exceed earnings and revenue expectations noteworthy. Analyst reactions to these results have not been specified in the recent updates. These developments reflect Civista Bancshares’ current financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.